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Abstract
The frequency of epilepsy in children with cerebral palsy is 40 times higher than the com-
mon population rate. The presence of epilepsy aggravates the clinical course of cerebral 
palsy, complicates the rehabilitation, affects the prognosis of motor and intellectual func-
tions, and could be life-threatening. Another problem is the possibility of aggravation 
of epileptic seizures and their appearance de novo due to application of some neuro-
rehabilitation methods (electrophoresis, acupuncture, nootropic drugs, brain stimula-
tors, etc.). Children with cerebral palsy have a broad spectrum of epilepsies—varying 
from favorable combinations with benign idiopathic forms to extremely severe epileptic 
encephalopathies. Frequent combination of epileptic and non-epileptic paroxysms causes 
difficulty in their interpretation and differential diagnosis. Video-EEG monitoring is the 
“golden standard” for differential diagnostic of epileptic and non-epileptic events, and 
it is very useful for investigation of patients with cerebral palsy. Treatment of epilepsy 
in combination with cerebral palsy strictly requires an individual approach due to the 
form of epilepsy, seizure types, age of the patient, comorbidity, and somatic and mental 
condition of the patient.
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1. Introduction
The actual problem is the presence of epileptic seizures in children with cerebral palsy that 
caused deterioration of disease, complicates the rehabilitation, affects the prognosis of motor 
and intellectual functions, and could be life-threatening. Also, the presence of epileptiform 
discharges with high index can cause progression of cognitive defects and also with possible 
increasing of motor deficits. These phenomena violate such a core criterion of cerebral palsy 
as nonprogressive process.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The frequency of neonatal seizures in children with cerebral palsy in 17 times is higher than com-
mon population rate, febrile seizures (2.5 times), and epilepsy (more than 40 times higher) [1].
Epilepsy in cerebral palsy occurs according to different authors data in 28% [2], 36.4% [3], 44% 
[4], 43.2% [1], 62% [5], and even 75% [6].
2. Cerebral palsy and epilepsy
2.1. Risk factors for epilepsy in cerebral palsy
Among infants at group of risk for the development of cerebral palsy and among those who 
had formed cerebral palsy are advisable to identify also the group of risk for development of 
epilepsy.
Risk factors for epilepsy in cerebral palsy are [1, 7–10]:
• The presence of neonatal seizures.
• Low Apgar score (≤4 points).
• Extremely preterm infants (≤31 weeks of gestation).
• Neonatal resuscitation.
• Family history of epilepsy.
• Cerebral palsy caused by prenatal factors, especially cerebral dysgenesis.
• Intrauterine infection (especially herpes encephalitis).
• Hemiplegic and tetraplegic forms of cerebral palsy.
• Severe mental retardation.
• The presence of epileptiform discharges on the EEG.
2.2. Characteristics of epilepsy in cerebral palsy
Despite the wide polymorphism of clinical cases, epilepsy in combination with cerebral palsy 
epilepsy has a number of common characteristics.
They can be expressed as the following features [1, 5, 7–11]:
1. In the majority of cases (up 74.2%), epilepsy in children with cerebral palsy debuted at the 
first year of life.
2. Children with cerebral palsy have a broad spectrum of epilepsies—varying from favorable 
combinations with benign idiopathic forms to extremely severe epileptic encephalopathies.
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3. Non-rare cerebral palsy is combined with epileptic encephalopathies of infancy and early 
childhood (Ohtahara, West, Markand-Blume-Ohtahara, Lennox-Gastaut syndromes, etc.).
4. The prevalence of the clinical picture of complex focal, secondarily generalized, and so-
called pseudo-generalized epileptic seizures (atypical absence, tonic spasms, and bilateral 
myoclonic seizures with focal origin).
5. Frequent combination of epileptic and non-epileptic paroxysms, as well as possible simi-
larity of their kinematics, causes difficulty in their interpretation and differential diagno-
sis. For example, the “dystonic attacks” with kinetic type of asymmetric tonic neck reflex 
(ATNR) and versive tonic epileptic seizures.
6. The presence of epilepsy aggravated motor and cognitive impairment in cerebral palsy. 
Frequently, epileptic seizures and epileptiform discharges with high index caused cogni-
tive epileptiform disintegration or partial cognitive defects, as well as a possible increase 
of motor deficits and progressive loss of certain motor and speech skills.
7. Frequent combination of cerebral palsy and benign epileptiform discharges of childhood 
(BEDC) on the EEG. Children with periventricular leukomalacia (PVL) and diffuse mye-
lination defects had favorable prognosis for epileptic seizures but in combination with 
drug-resistant epileptiform discharges (including BEDC) and disintegrative epileptiform 
processes.
8. In children with cerebral palsy (unless caused by cerebral dysgenesis) may not be a cor-
relation between the sites of epileptiform activity and the area most pronounced structural 
changes in neuroimaging.
9. There is often a reflex provocation under the influence of audiogenic seizures and soma-
tosensory stimulation (including epilepsy of feeding). The problem of differential diagno-
sis of startle reflex and startle epilepsy in children with cerebral palsy.
10. Increased risk of recurrence of epilepsy in children with cerebral palsy after antiepileptic 
drug (AED) discontinuation.
Children with cerebral palsy have a wide spectrum of epilepsies which varies from favorable 
combinations with benign idiopathic forms to extremely severe epileptic encephalopathies.
So, in the total of 231 pediatric cases of cerebral palsy observed and treated on the Department 
of Psychoneurology N2 Russian Children Clinical Hospital (Moscow) at 2007–2012 years, 84 
children (36.4%) had a combination of cerebral palsy and epilepsy [3].
The following forms of epilepsy were fixed: symptomatic focal frontal lobe epilepsy 
(25 patients (29.7%)), temporal lobe epilepsy (15 patients (17.9%)), parietal lobe epilepsy 
(3 patients (3.6%)), occipital lobe epilepsy (8 patients (9.5%)), SE-MISF (severe epilepsy with 
multifocal independent spike foci or Markand-Blume-Ohtahara syndrome) (7 patients (8.3%)), 
other multifocal epilepsies (4 patients (4.8%)), West syndrome (5 patients (6%)), focal epilepsy 
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of childhood with structural brain changes and benign epileptiform discharges of childhood 
on the EEG (FECSBC-BEDC) (10 patients (11.9%)), and cognitive epileptiform disintegration 
(CED) with ESES (electrical status epilepticus at slow-wave sleep) (7 patients (8.3%)) [3].
2.3. Epileptiform activity in children with cerebral palsy and epilepsy
Morphologic characteristics of epileptiform activity in children with cerebral palsy and epi-
lepsy are very different and depend on the form of epilepsy, patient age, severity, and nature 
of brain damage.
In children with cerebral palsy, the high frequency of so-called benign epileptiform discharges 
of childhood pattern (“BEDC,” “BEDOC,” or “Rolandic” spikes and spike-wave complexes) 
was noted and could be found in epileptic (Figures 1 and 2) and also non-epileptic patients.
Over the past decades, the world’s scientific and clinical experience accumulates the observa-
tion of patients with the so-called double pathology—the presence of structural brain damages 
with motor deficit in combination with epileptic idiopathic component including “BEDC.”
Mukhin et al. proposed the definition “focal epilepsy of childhood with structural brain 
changes and benign epileptiform discharges in EEG” (“FECSBC-BEDC”) for the group of 
children with focal epilepsy, associated with BEDC on EEG and perinatal organic brain dam-
age, which has a special “interim” position between idiopathic and symptomatic epilepsies 
due to its clinical electrical and neuroimaging characteristics [12].
Figure 1. Boy Sh.I. (7 years old). Hemiparetic form of cerebral palsy (right-side hemiparesis). Symptomatic focal epilepsy 
with right-side hemiconvulsive, versive, dialeptic, and myoclonic-astatic seizure types. Porencephalic cyst in the left 
hemisphere (parietotemporal region).
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High index (85–100% of recording) of such spikes-waves in sleep formed EEG patterns of 
CSWS (continuous spikes-and-waves during sleep) and ESES (electrical status epilepticus in 
sleep) in cases of diffuse spreading of epileptiform discharges (Figure 3). It usually correlates 
with severe speech and cognitive deficit in children.
Sometimes, early appearance on the EEG “BEDC”-like complexes is prognostically unfavor-
able and preceding the development of hypsarrhythmia. Five-point epileptiform complexes 
as “Rolandic” at the first months of life in children with hypoxic-ischemic brain damage and 
periventricular leukomalacia could precede hypsarrhythmia, epileptic spasms, and the devel-
opment of epileptic encephalopathy (Figures 4–7).
Figure 2. Boy Sh.I. (7 years old) (the same patient). Wake EEG. Regional epileptiform activity in left central and centro-
parietotemporal region in the manner of spike-wave with “BEDC” morphology and sharp- and slow-wave complexes 
in combination with regional slowing.
Figure 3. Girl V.M. (11 years old). Cerebral palsy, moderate right-side hemiparesis. Sleep EEG-ESES pattern.
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Frequent combination of epileptic seizures and non-epileptic events, as well as possible simi-
larity of their kinematics, causes difficulty in their interpretation and differential diagnosis. 
For example, we can see EEG illustrations (Figures 8–12) of the girl N.A. (age 1 year and 
3 months); we can see her interictal EEG pattern and patterns of non-epileptic event and ictal 
recording. Surprisingly, events considered as asymmetric tonic versive seizures were diag-
nosed as non-epileptic, but video-EEG also demonstrated minimal motor seizures of temporal 
Figure 4. Boy B-H.A. (4 months old). Retardation of psychomotor and preverbal development due to perinatal brain 
damage. Risk of cerebral palsy. EEG during wakefulness 2 months before the onset of infantile spasms. In the center-
right parietal region, low-amplitude five-pointed epileptiform complexes are observed, similar in morphology to the 
“Rolandic” complexes.
Figure 5. The same patient (4 months later; age of 8 months). Spastic tetraparesis. Infantile spasms. Psychomotor 
retardation. EEG during wakefulness: modified hypsarrhythmia with a multiregional component (right parietal, left 
and right frontal areas).
Cerebral Palsy - Clinical and Therapeutic Aspects70
lobe genesis not considered by the father of the child and even the physicians. The girl had 
spastic tetraplegic-type cerebral palsy, microcephaly, symptomatic focal epilepsy, pseudobul-
bar syndrome, chronic aspiration syndrome, and severe delay of psychomotor development. 
According to the anamnesis data, the mother 34 years old, and the father is 50 years old. 
The girl from the first physiological pregnancy, delivery at the 40th month of gestation. Her 
mother died during status epilepticus of bilateral tonic-clonic seizures. Mechanic extraction 
of the child with obstetric forceps from dying mother. The girl was born with weight 3510 g, 
Figure 7. The same patient (age of 8 months). EEG during a series of tonic axial and axiorhizomelic flexor epileptic 
spasms. Marked diffuse ictal runs of “low-amplitude fast activity” (“lafa”) and “fast activity” with predominant right-
hemisphere parietal involvement and postictal partial inhibition of bioelectric activity.
Figure 6. The same patient (age of 8 months). EEG during sleep: modified hypsarrhythmia with persistence of 
suppression burst pattern and main regional focus in the right parietal area.
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length of 53 cm, and Apgar score of 4/5 degrees. She was on the artificial lung ventilation for 
3 weeks. Neonatal seizures appear from the first days of life.
Esipova E.S. and coauthors (2017) have analyzed video-EEG monitoring results of 133 children 
(87 boys and 46 girls) with spastic forms of cerebral palsy who underwent examination and 
Figure 8. Girl N.A. (1 year and 3 months). Cerebral palsy. Interictal EEG with “BEDC” complexes of the left and 
independently right temporal, temporo-central, and temporoparietal localization.
Figure 9. The same girl and EEG record. EEG of non-epileptic paroxysm (the beginning)—“dystonic attacks” with 
kinetic type of asymmetric tonic neck reflex (ATNR). No ictal pattern. Movement artifacts with the same background 
interictal “BEDC” complexes.
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treatment at the Department of Psychoneurology N2 Russian Children Clinical Hospital in 
2014–2016 years. In a group of spasic tetraparesis (n = 79), the presence of epilepsy was 54.43% 
(n = 43), and the presence of epileptiform activity on the EEG was 72.15% (n = 57) including 
24 children (30.38%) with “benign epileptiform discharges of childhood” (“BEDC”). In a group 
of spastic hemiparesis (n = 18), the presence of epilepsy was 27.78% (n = 5), but the presence 
of epileptiform activity on the EEG was 61.11% (n = 11) including 8 children (44.45%) with 
Figure 10. The same girl and EEG record. The end of non-epileptic paroxysm.
Figure 11. The same girl and EEG record. The ictal event—minimal motor seizure (“subtile” bilateral spasm with 
dystonic set of the right hand) with “fast activity” pattern in the left temporal region.
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“BEDC.” In a group of Little’s disease (spastic diplegia) (n = 25), the presence of epilepsy was 
20% (n = 5), and the presence of epileptiform activity was 48% (n = 12) including 7 children 
(28%) with “BEDC.” Mixed form of cerebral palsy (n = 11) contains seven epileptic patients, 
and the presence of epileptiform activity was 72.73% (n = 8) including 5 children (45.45%) 
with “BEDC.” Among the 133 children, 72.2% (n = 96) of all the presented patients had non-
epileptic paroxysms on the EEG considered by parents and also mentioned by EEG assistants. 
In 18.1% (n = 24) of patients, a combination of epileptic and non-epileptic events on the video-
EEG monitoring was fixed. In 13 patients only epileptic events were fixed (9.7%) [13].
2.4. Treatment of epilepsy in children with cerebral palsy
Drugs of choice in the treatment of epilepsy in children are valproates in doses of 20–100 mg/
kg/daily. It should be emphasized that the high incidence of bulbar palsy disorders in chil-
dren causes serious problems with the use of tablet and capsule forms of antiepileptic drugs 
(AEDs). This problem has been solved by the use of such forms of valproates such as depakine 
chronosphere, depakine syrup, convulex in the syrup and drops form, etc.
In cases of atypical absences and BEDC-associated conditions, succinimides (suxilep, petni-
dan) at doses 20–35 mg/kg/day are appropriate.
In children with cerebral palsy and cognitive epileptiform disintegration with BEDC on EEG, 
also levetiracetam (keppra, epiterra, levetinol) in doses 20–80 mg/kg/day could be very good.
In application of carbamazepine group, oxcarbazepine, lamotrigine, and topiramate in pedi-
atric patients under the age of 7 years should be considered the high risk of aggravation of the 
Figure 12. The same girl and EEG record. The end of ictal event—“fast activity” pattern in the left temporal region 
stopped.
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phenomenon of secondary bilateral synchronization of the EEG, with clinical manifestations 
of myoclonic seizures, atypical absences, and secondarily generalized seizures. This group 
of drugs to be combined with a broad-spectrum AED with low aggravation risk (as valpro-
ates) and their use requires careful dynamic video-EEG monitoring to detect early signs of 
aggravation. But carbamazepine, oxcarbazepine, eslicarbazepine acetate, lamotrigine, and 
topiramate could be very useful in focal tonic and clonic seizures. In older children and adult 
patients, topiramate is one of the best drugs in frontal lobe epilepsy with secondary bilateral 
synchronization. Carbamazepine group and oxcarbazepine are better in temporal and occipi-
tal localization of epileptic focus.
In frequent epileptic seizures, especially myoclonic types, benzodiazepines are very useful 
(clonazepam 0.1–0.3 mg/kg/daily, frisium 0.3–1 mg/kg/daily). Benzodiazepines may also be 
helpful to reduce muscle tonus and decreased expression of dystonic non-epileptic attacks.
In young children with cerebral dysgenesis, vigabatrin may be effective in treatment (30–
150 mg/kg/daily). It is useful to give predominant part or total daily dose at the evening for 
peak of drug concentration in blood at the dark for preventing retinotoxicity.
In prolonged clusters of seizures and status epilepticus - diazepam in rectal tubes, buccal 
or nasal midazolam, benzodiazepines i.m., i.v. In benzodiazepine-resistant status epilepti-
cus and in tonic-autonomic seizures with apnea and bradyarrhythmia, valproates strictly i.v. 
(depakin, convulex) is recommended.
In consideration with the high risk of seizure recurrence and severity of epilepsy structural 
defects of the brain in patients with cerebral palsy, the duration of antiepileptic therapy 
should be at least 3 years after achieving clinical remission (usually for ≥5 years).
In the presence of drug-resistant epilepsy, it is necessary to decide on the possibility of epi-
leptic surgery, which will be appropriate for cerebral dysgenesis, especially in cases of focal 
cortical dysplasia. On the contrary, the presence of a structural defect of hypoxic-ischemic 
or posthemorrhagic genesis and epileptiform discharge “BEDC” type in contralateral (in 
potentially “healthy” hemisphere as a result of a combination of cerebral palsy and idiopathic 
epileptic component) is a contraindication for epileptic surgery.
In cases of pharmacoresistance and impossibility or absence of indications for surgical treat-
ment, VNS therapy (implantation of a vagus nerve stimulator) may be considered.
The serious problem is the possibility of aggravation of epileptic seizures and their appear-
ance de novo due to application of some neurorehabilitation methods (electrophoresis, acu-
puncture, electroretinostimulation, application of nootropic drugs and brain stimulators, 
etc.). Of course, rehabilitation methods in every child will individually depend on motor 
and mental skills and the severity of epileptiform process. Reflex locomotion gymnastic (the 
Vojta method) and neurodynamic rehabilitation therapy (the Bobath method) have minimal 
epilepsy aggravation risk and are strongly recommended for all children with motor retarda-
tion as well as in cases of cerebral palsy with epilepsy and epileptiform activity. Metabolic 
l-carnitine treatment is very useful for patients with cerebral palsy especially in cases of pro-
long antiepileptic therapy (extremely important in long-term therapy with valproates causing 
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carnitine deficiency). Peptidergic nootropic therapy in cerebral palsy associated with epilepsy 
also demonstrated its efficiency and safety [14].
3. Conclusions
• Epilepsy is non-rare condition in patients with spastic forms of cerebral palsy.
• The presence of epilepsy aggravates the clinical course of cerebral palsy, complicates 
the rehabilitation, affects the prognosis of motor and intellectual functions, and could be 
life-threatening.
• Frequent combination of epileptic and non-epileptic paroxysms, as well as possible similar-
ity of their kinematics, causes difficulty in their interpretation and differential diagnosis.
• Video-EEG monitoring as a “golden standard” for differential diagnostic of epileptic and 
non-epileptic events is very useful for investigation of patients with cerebral palsy. Sleep 
EEG is very important for detection of epileptiform discharges especially in children with 
CSWS or ESES pattern.
• Treatment of epilepsy in combination with cerebral palsy strictly requires an individual 
approach due to the form of epilepsy, seizure types, age of the patient, comorbidity, and 
somatic and mental condition of the patient.
• The presence of epilepsy is not a contraindication for rehabilitation and nootropic treat-
ment. But we need to use methods with minimal risk of possibility for aggravation of sei-
zures and epileptiform discharges.
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